Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies
Clinical trial NCT00536978 · COMPLETED
Trial details
- NCT number
- NCT00536978
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-11-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.